ID   LaNCE hiPSC-40
AC   CVCL_WR90
SY   hiPSC-40; iPS-40-ACA; iPS-40; iPS-PD3; LANCEi016-A
DR   hPSCreg; LANCEi016-A
DR   Wikidata; Q95981251
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 10
ST   D18S51: 15,18
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 16,22
ST   D3S1358: 16,17
ST   D5S818: 7,12
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
RX   PubMed=29433076; DOI=10.1016/j.scr.2018.01.030;
RA   Sarafian, Raquel Delgado
RA   Morato-Marques, Mariana
RA   Borsoi, Juliana
RA   Pereira, Lygia Veiga
RT   "Monitoring cell line identity in collections of human induced
RT   pluripotent stem cells.";
RL   Stem Cell Res. 28:66-70(2018).
//
RX   PubMed=31710912; DOI=10.1016/j.scr.2019.101640;
RA   Tofoli de Araujo, Fabiano
RA   Chien, Hsin-Fen
RA   Barbosa, Egberto Reis
RA   Pereira, Lygia Veiga
RT   "Generation of 5 hiPSC lines derived from three unrelated idiopathic
RT   Parkinson disease patients and two unrelated healthy control
RT   individuals.";
RL   Stem Cell Res. 41:101640-101640(2019).
//